| abstract |
FIELD: medicine, psychopharmacology. n SUBSTANCE: invention proposes using bioactive metabolite of hepirone for preparing a medicinal agent designated for reducing the depression severity or anxiety or their symptoms in mammals. Agent is chosen from the group comprising 3-(OH)-hepirone, 3,5-dihydroxyhepirone, 5-(OH)-hepirone or its pharmaceutically acceptable salt or hydrate. Invention expands the assortment of medicinal agents used in psychiatry. n EFFECT: valuable medicinal properties of metabolites. n 4 cl, 2 dwg, 5 ex |